Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Jan;233(1):13-20.
doi: 10.1007/BF00177780.

Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma

E Gramer  1 , S Busche, A Kampik, D Parsons
Affiliations

Efficacy of apraclonidine ophthalmic solution (Iopidine) in presumed silicon oil-induced glaucoma and primary open-angle glaucoma

E Gramer et al. Graefes Arch Clin Exp Ophthalmol. 1995 Jan.

Abstract

Background: This pilot study evaluated the acute effects of topical ocular apraclonidine 1% (Iopidine) in 10 patients with presumed silicone oil-induced secondary glaucoma (SOIG) and in 10 patients with high-pressure primary open-angle glaucoma (POAG) despite maximum tolerated medical therapy.

Methods: Intraocular pressure (IOP) measurements were carried out before and 1, 2 and 3 h after a single drop of apraclonidine.

Results: Patients with SIOG presented with a mean IOP of 30.0 +/- 2.8 mmHg, which was reduced to 21.7 +/- 2.9 mmHg (P < 0.001) after 1 h, to 20.4 +/- 2.3 mmHg (P < 0.001) after 2 h and to 20.0 +/- 2.5 mmHg (P < 0.001) after 3 h. In the POAG group, IOP was reduced from 25.9 +/- 1.9 mmHg before treatment to 18.9 +/- 1.4 mmHg after 1 h (P < 0.001), 17.7 +/- 1.2 mmHg after 2 h (P < 0.001) and 16.9 +/- 0.9 mmHg after 3 h (P < 0.001). There were no significant changes in blood pressure or pulse rate.

Conclusion: This study confirmed the activity of apraclonidine as an IOP suppressant.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 1988 Aug;106(8):1069-73 - PubMed
    1. Arch Ophthalmol. 1987 Sep;105(9):1208-11 - PubMed
    1. Arch Ophthalmol. 1967 Feb;77(2):185-96 - PubMed
    1. Eur J Pharmacol. 1987 Feb 10;134(2):123-9 - PubMed
    1. Arch Ophthalmol. 1987 May;105(5):646-50 - PubMed

Publication types

MeSH terms

LinkOut - more resources